BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9169475)

  • 1. Isolation and characterization of the human gp130 promoter. Regulation by STATS.
    O'Brien CA; Manolagas SC
    J Biol Chem; 1997 Jun; 272(23):15003-10. PubMed ID: 9169475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes.
    Fujio Y; Kunisada K; Hirota H; Yamauchi-Takihara K; Kishimoto T
    J Clin Invest; 1997 Jun; 99(12):2898-905. PubMed ID: 9185513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase.
    Boulton TG; Zhong Z; Wen Z; Darnell JE; Stahl N; Yancopoulos GD
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6915-9. PubMed ID: 7624343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
    Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytoplasmic tyrosine motifs in full-length glycoprotein 130 have different roles in IL-6 signal transduction.
    Schmitz J; Dahmen H; Grimm C; Gendo C; Müller-Newen G; Heinrich PC; Schaper F
    J Immunol; 2000 Jan; 164(2):848-54. PubMed ID: 10623831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT protein complexes activated by interferon-gamma and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties.
    Lamb P; Seidel HM; Haslam J; Milocco L; Kessler LV; Stein RB; Rosen J
    Nucleic Acids Res; 1995 Aug; 23(16):3283-9. PubMed ID: 7667105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation.
    Gerhartz C; Heesel B; Sasse J; Hemmann U; Landgraf C; Schneider-Mergener J; Horn F; Heinrich PC; Graeve L
    J Biol Chem; 1996 May; 271(22):12991-8. PubMed ID: 8662591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. II. Src homology SH2 domains define the specificity of stat factor activation.
    Hemmann U; Gerhartz C; Heesel B; Sasse J; Kurapkat G; Grötzinger J; Wollmer A; Zhong Z; Darnell JE; Graeve L; Heinrich PC; Horn F
    J Biol Chem; 1996 May; 271(22):12999-3007. PubMed ID: 8662795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
    Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3.
    Auernhammer CJ; Isele NB; Kopp FB; Spoettl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
    Endocrinology; 2003 Apr; 144(4):1202-10. PubMed ID: 12639901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of an interferon-gamma Stat3 response in nerve cells by pre-treatment with gp130 cytokines.
    Kaur N; Kim IJ; Higgins D; Halvorsen SW
    J Neurochem; 2003 Oct; 87(2):437-47. PubMed ID: 14511121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 is required for the gp130-mediated full activation of the c-myc gene.
    Kiuchi N; Nakajima K; Ichiba M; Fukada T; Narimatsu M; Mizuno K; Hibi M; Hirano T
    J Exp Med; 1999 Jan; 189(1):63-73. PubMed ID: 9874564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The carboxyl-terminal region of STAT3 controls gene induction by the mouse haptoglobin promoter.
    Kim H; Baumann H
    J Biol Chem; 1997 Jun; 272(23):14571-9. PubMed ID: 9169415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins.
    Schumann RR; Kirschning CJ; Unbehaun A; Aberle HP; Knope HP; Lamping N; Ulevitch RJ; Herrmann F
    Mol Cell Biol; 1996 Jul; 16(7):3490-503. PubMed ID: 8668165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
    Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
    Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of gp130 and differential activation of STAT and p42/44 MAPK in the rat hippocampus following kainic acid-induced seizures.
    Choi JS; Kim SY; Park HJ; Cha JH; Choi YS; Kang JE; Chung JW; Chun MH; Lee MY
    Brain Res Mol Brain Res; 2003 Nov; 119(1):10-8. PubMed ID: 14597225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
    FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the interleukin-6 receptor subunit glycoprotein 130 complex and its signaling by LMO4 interaction.
    Novotny-Diermayr V; Lin B; Gu L; Cao X
    J Biol Chem; 2005 Apr; 280(13):12747-57. PubMed ID: 15677447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.